Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
NCT06204549
Summary
The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management of cardiovascular risk in patients at high cardiovascular risk, whether in primary prevention or secondary prevention. During planned hospitalization, patients benefit from comprehensive, personalized and adapted care for their comorbidities and their CVRF (cardiovascular risk factors). This study will make it possible to evaluate this overall course of multidisciplinary management of comorbidities of patients at high cardiovascular risk.
Eligibility
Inclusion Criteria: * High-Risk Cardiovascular patients either receiving: * Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis * Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure * Aged 18 and over * Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department. Exclusion Criteria: * Patient refusal * Subject not registered in social security system * Pregnant or breastfeeding woman * Patient unable to give their informed consent, protected adult, vulnerable people * Subject deprived of liberty by judicial or administrative decision
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06204549